AAAAAA

   
Results: 1-24 |
Results: 24
Phospholipid abnormalities in postmortem schizophrenic brains detected by P-31 nuclear magnetic resonance spectroscopy: a preliminary study
Authors: Komoroski, RA Pearce, JM Griffin, WST Mrak, RE Omori, M Karson, CN
Citation: Ra. Komoroski et al., Phospholipid abnormalities in postmortem schizophrenic brains detected by P-31 nuclear magnetic resonance spectroscopy: a preliminary study, PSYCH RES-N, 106(3), 2001, pp. 171-180
Vitamin E suppression of microglial activation is neuroprotective
Authors: Li, YK Liu, L Barger, SW Mrak, RE Griffin, WST
Citation: Yk. Li et al., Vitamin E suppression of microglial activation is neuroprotective, J NEUROSC R, 66(2), 2001, pp. 163-170
Interleukin-1 promotion of MAPK-p38 overexpression in experimental animalsand in Alzheimer's disease: potential significance for tau protein phosphorylation
Authors: Sheng, JG Jones, RA Zhou, XQ McGinness, JM Van Eldik, LJ Mrak, RE Griffin, WST
Citation: Jg. Sheng et al., Interleukin-1 promotion of MAPK-p38 overexpression in experimental animalsand in Alzheimer's disease: potential significance for tau protein phosphorylation, NEUROCHEM I, 39(5-6), 2001, pp. 341-348
Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer'sdisease
Authors: Peskind, ER Griffin, WST Akama, KT Raskind, MA Van Eldik, LJ
Citation: Er. Peskind et al., Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer'sdisease, NEUROCHEM I, 39(5-6), 2001, pp. 409-413
Glial cells in Alzheimer's disease
Authors: Mrak, RE Griffin, WST
Citation: Re. Mrak et Wst. Griffin, Glial cells in Alzheimer's disease, CONT CLIN N, 2001, pp. 73-86
The pervasiveness of interleukin-1 in Alzheimer pathogenesis: a role for specific polymorphisms in disease risk
Authors: Griffin, WST Nicoll, JAR Grimaldi, LME Sheng, JG Mrak, RE
Citation: Wst. Griffin et al., The pervasiveness of interleukin-1 in Alzheimer pathogenesis: a role for specific polymorphisms in disease risk, EXP GERONT, 35(4), 2000, pp. 481-487
Genetic association studies of interleukin-1 (IL-1A and IL-1B) and interleukin-1 receptor antagonist genes and the risk of Alzheimer's disease - Reply
Authors: Grimaldi, LME Griffin, WST
Citation: Lme. Grimaldi et Wst. Griffin, Genetic association studies of interleukin-1 (IL-1A and IL-1B) and interleukin-1 receptor antagonist genes and the risk of Alzheimer's disease - Reply, ANN NEUROL, 48(5), 2000, pp. 818-819
Association of early-onset disease with an Alzheimer's disease with an interleukin-1 alpha gene polymorphism
Authors: Grimaldi, LME Casadei, VM Ferri, C Veglia, F Licastro, F Annoni, G Biunno, I De Bellis, G Sorbi, S Mariani, C Canal, N Griffin, WST Franceschi, M
Citation: Lme. Grimaldi et al., Association of early-onset disease with an Alzheimer's disease with an interleukin-1 alpha gene polymorphism, ANN NEUROL, 47(3), 2000, pp. 361-365
Association of interleukin-1 gene polymorphisms with Alzheimer's disease
Authors: Nicoll, JAR Mrak, RE Graham, DI Stewart, J Wilcock, G MacGowan, S Esiri, MM Murray, LS Dewar, D Love, S Moss, T Griffin, WST
Citation: Jar. Nicoll et al., Association of interleukin-1 gene polymorphisms with Alzheimer's disease, ANN NEUROL, 47(3), 2000, pp. 365-368
Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression
Authors: Li, YK Liu, L Kang, JS Sheng, JG Barger, SW Mrak, RE Griffin, WST
Citation: Yk. Li et al., Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression, J NEUROSC, 20(1), 2000, pp. 149-155
Inflammation and Alzheimer's disease
Authors: Akiyama, H Barger, S Barnum, S Bradt, B Bauer, J Cole, GM Cooper, NR Eikelenboom, P Emmerling, M Fiebich, BL Finch, CE Frautschy, S Griffin, WST Hampel, H Hull, M Landreth, G Lue, LF Mrak, R Mackenzie, IR McGeer, PL O'Banion, MK Pachter, J Pasinetti, G Plata-Salaman, C Rogers, J Rydel, R Shen, Y Streit, W Strohmeyer, R Tooyoma, I Van Muiswinkel, FL Veerhuis, R Walker, D Webster, S Wegrzyniak, B Wenk, G Wyss-Coray, T
Citation: H. Akiyama et al., Inflammation and Alzheimer's disease, NEUROBIOL A, 21(3), 2000, pp. 383-421
Association of an interleukin 1 alpha polymorphism with Alzheimer's disease
Authors: Du, Y Dodel, RC Eastwood, BJ Bales, KR Gao, F Lohmuller, F Muller, U Kurz, A Zimmer, R Evans, RM Hake, A Gasser, T Oertel, WH Griffin, WST Paul, SM Farlow, MR
Citation: Y. Du et al., Association of an interleukin 1 alpha polymorphism with Alzheimer's disease, NEUROLOGY, 55(4), 2000, pp. 480-483
Interleukin-1 and the immunogenetics of Alzheimer disease
Authors: Mrak, RE Griffin, WST
Citation: Re. Mrak et Wst. Griffin, Interleukin-1 and the immunogenetics of Alzheimer disease, J NE EXP NE, 59(6), 2000, pp. 471-476
S100 beta induction of the proinflammatory cytokine interleukin-6 in neurons
Authors: Li, YK Barger, SW Liu, L Mrak, RE Griffin, WST
Citation: Yk. Li et al., S100 beta induction of the proinflammatory cytokine interleukin-6 in neurons, J NEUROCHEM, 74(1), 2000, pp. 143-150
Overexpression of the neuritotrophic cytokine S100 beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice
Authors: Sheng, JG Mrak, RE Bales, KR Cordell, B Paul, SM Jones, RA Woodward, S Zhou, XQ McGinness, JM Griffin, WST
Citation: Jg. Sheng et al., Overexpression of the neuritotrophic cytokine S100 beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice, J NEUROCHEM, 74(1), 2000, pp. 295-301
Interleukin-1 promotes expression and phosphorylation of neurofilament andtau proteins in vivo
Authors: Sheng, JG Zhu, SG Jones, RA Griffin, WST Mrak, RE
Citation: Jg. Sheng et al., Interleukin-1 promotes expression and phosphorylation of neurofilament andtau proteins in vivo, EXP NEUROL, 163(2), 2000, pp. 388-391
Increased levels of transcription factors Elk-1, cyclic adenosine monophosphate response element-binding protein, and activating transcription factor2 in the cerebellar vermis of schizophrenic patients
Authors: Kyosseva, SV Elbein, AD Hutton, TL Griffin, WST Mrak, RE Sturner, WQ Karson, CN
Citation: Sv. Kyosseva et al., Increased levels of transcription factors Elk-1, cyclic adenosine monophosphate response element-binding protein, and activating transcription factor2 in the cerebellar vermis of schizophrenic patients, ARCH G PSYC, 57(7), 2000, pp. 685-691
Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'
Authors: Karson, CN Mrak, RE Schluterman, KO Sturner, WQ Sheng, JG Griffin, WST
Citation: Cn. Karson et al., Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality', MOL PSYCHI, 4(1), 1999, pp. 39-45
Evidence for caspase-mediated cleavage of AMPA receptor subunits in neuronal apoptosis and Alzheimer's disease
Authors: Chan, SL Griffin, WST Mattson, MP
Citation: Sl. Chan et al., Evidence for caspase-mediated cleavage of AMPA receptor subunits in neuronal apoptosis and Alzheimer's disease, J NEUROSC R, 57(3), 1999, pp. 315-323
Overexpression of S100 beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition
Authors: Royston, MC McKenzie, JE Gentleman, SM Sheng, JG Mann, DMA Griffin, WST Mrak, RE
Citation: Mc. Royston et al., Overexpression of S100 beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition, NEUROP AP N, 25(5), 1999, pp. 387-393
Is there a genetic basis for the deposition of beta-amyloid after fatal head injury?
Authors: Graham, DI Gentleman, SM Nicoll, JAR Royston, MC McKenzie, JE Roberts, GW Mrak, RE Griffin, WST
Citation: Di. Graham et al., Is there a genetic basis for the deposition of beta-amyloid after fatal head injury?, CELL MOL N, 19(1), 1999, pp. 19-30
Increased interleukin-1 beta converting enzyme expression and activity in Alzheimer disease
Authors: Zhu, SG Sheng, JG Jones, RA Brewer, MM Zhou, XQ Mrak, RE Griffin, WST
Citation: Sg. Zhu et al., Increased interleukin-1 beta converting enzyme expression and activity in Alzheimer disease, J NE EXP NE, 58(6), 1999, pp. 582-587
Mitogen-activated protein kinases in schizophrenia
Authors: Kyosseva, SV Elbein, AD Griffin, WST Mrak, RE Lyon, M Karson, CN
Citation: Sv. Kyosseva et al., Mitogen-activated protein kinases in schizophrenia, BIOL PSYCHI, 46(5), 1999, pp. 689-696
Life-long overexpression of S100 beta in Down's syndrome: Implications forAlzheimer pathogenesis
Authors: Griffin, WST Sheng, JG McKenzie, JE Royston, MC Gentleman, SM Brumback, RA Cork, LC Del Bigio, MR Roberts, GW Mrak, RE
Citation: Wst. Griffin et al., Life-long overexpression of S100 beta in Down's syndrome: Implications forAlzheimer pathogenesis, NEUROBIOL A, 19(5), 1998, pp. 401-405
Risultati: 1-24 |